Trichosporon beigelii: a life-threatening pathogen in immunocompromised hosts (Q33879950)

29 July 2017

title

Trichosporon beigelii: a life-threatening pathogen in immunocompromised hosts (English)

1 reference

29 July 2017

main subject

Trichosporon beigelii

object named as

Trichosporon beigelii

1 reference

Erer B

1

1 reference

29 July 2017

Galimberti M

2

1 reference

29 July 2017

Lucarelli G

3

1 reference

29 July 2017

Giardini C

4

1 reference

29 July 2017

Polchi P

5

1 reference

29 July 2017

Baronciani D

6

1 reference

29 July 2017

Gaziev D

7

1 reference

29 July 2017

Angelucci E

8

1 reference

29 July 2017

Izzi G

9

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 April 2000

1 reference

Bone Marrow Transplantation

29 July 2017

published in

1 reference

29 July 2017

volume

25

1 reference

29 July 2017

issue

7

1 reference

29 July 2017

page(s)

745-749

1 reference

Trichosporon cutaneum endocarditis: a sequela of intravenous drug abuse

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702231

Cysto-peritoneal shunt infection withTrichosporon beigelii

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702231

Postoperative endophthalmitis due to Trichosporon cutaneum

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702231

Bone marrow transplantation in patients with thalassemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702231

A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702231

Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation--a prospective, randomized, double-blind study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702231

Prediction of systemic fungal infection in allogeneic marrow recipients: impact of amphotericin prophylaxis in high-risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702231

The new fungal opportunists are coming

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702231

Brain Abscess Due To Trichosporon Cutaneum

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702231

Long-term survival of a patient with prosthetic valve endocarditis due toTrichosporon beigelii

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702231

Azole therapy for trichosporonosis: clinical evaluation of eight patients, experimental therapy for murine infection, and review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702231

Trichosporon beigelii, a new neonatal pathogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702231

7 January 2021

Endocarditis Due to Trichosporon beigelii: In Vitro Susceptibility of Isolates and Review

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702231

7 January 2021

A case of Trichosporon beigelii peritonitis in CAPD

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702231

7 January 2021

Chronic meningitis caused by Trichosporon beigelii in India

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702231

7 January 2021

Fatal fungemia with arthritic involvement caused by Trichosporon beigelii in a bone marrow transplant recipient

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702231

7 January 2021

Assignment and serotyping of Trichosporon species: the causative agents of summer-type hypersensitivity pneumonitis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702231

7 January 2021

Antifungal susceptibility testing of Trichosporon beigelii to imidazole compounds

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702231

7 January 2021

Trichosporon beigelii, an emerging pathogen resistant to amphotericin B

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702231

7 January 2021

Controlled study of fluconazole in the prevention of fungal infections in neutropenic patients with haematological malignancies and bone marrow transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702231

7 January 2021

Prosthetic valve endocarditis caused by trichosporon beigelii

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702231

7 January 2021

Detection of a Trichosporon beigelii antigen cross-reactive with Cryptococcus neoformans capsular polysaccharide in serum from a patient with disseminated Trichosporon infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702231

7 January 2021

Role of the latex agglutination test for cryptococcal antigen in diagnosing disseminated infections with Trichosporon beigelii

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702231

7 January 2021

In vitro susceptibility of Trichosporon beigelii to antifungal agents

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702231

7 January 2021

In vitro amphotericin B resistance in clinical isolates of Aspergillus terreus, with a head-to-head comparison to voriconazole.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702231

7 January 2021

In vitro evaluation of voriconazole against clinical isolates of yeasts, moulds and dermatophytes in comparison with itraconazole, ketoconazole, amphotericin B and griseofulvin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702231

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1702231

1 reference

Dimensions Publication ID

29 July 2017

1020188354

0 references

1 reference